BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wilcox RA. Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management. Am J Hematol 2017;92:1085-102. [PMID: 28872191 DOI: 10.1002/ajh.24876] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 12.8] [Reference Citation Analysis]
Number Citing Articles
1 Hristov AC, Tejasvi T, Wilcox RA. Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk-stratification, and management. Am J Hematol 2019;94:1027-41. [PMID: 31313347 DOI: 10.1002/ajh.25577] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
2 Brunner PM, Jonak C, Knobler R. Recent advances in understanding and managing cutaneous T-cell lymphomas. F1000Res 2020;9:F1000 Faculty Rev-331. [PMID: 32419924 DOI: 10.12688/f1000research.21922.1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
3 Larocca CA, LeBoeuf NR. Overview of Cutaneous T-Cell Lymphomas. Hematol Oncol Clin North Am 2019;33:669-86. [PMID: 31229162 DOI: 10.1016/j.hoc.2019.04.004] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
4 Barrios DM, Do MH, Phillips GS, Postow MA, Akaike T, Nghiem P, Lacouture ME. Immune checkpoint inhibitors to treat cutaneous malignancies. J Am Acad Dermatol 2020;83:1239-53. [PMID: 32461079 DOI: 10.1016/j.jaad.2020.03.131] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
5 Yuan S, Liu Z, Xu Z, Liu J, Zhang J. High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies. J Hematol Oncol 2020;13:91. [PMID: 32660524 DOI: 10.1186/s13045-020-00920-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
6 Tanase C, Popescu ID, Enciu AM, Gheorghisan-Galateanu AA, Codrici E, Mihai S, Albulescu L, Necula L, Albulescu R. Angiogenesis in cutaneous T-cell lymphoma - proteomic approaches. Oncol Lett 2019;17:4060-7. [PMID: 30944599 DOI: 10.3892/ol.2018.9734] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Lebas E, Chapelier C, Quatresooz P, Seidel L, Nikkels AF. Exploratory Assessment of Oxygen Flow-Assisted Cutaneous Administration of Methotrexate for Superficial Basal Cell Carcinoma, Mycosis Fungoides, and Extramammary Paget Disease. J Invest Dermatol 2020;140:583-92. [PMID: 31513804 DOI: 10.1016/j.jid.2019.08.443] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Bagot M, Porcu P, Marie-Cardine A, Battistella M, William BM, Vermeer M, Whittaker S, Rotolo F, Ram-Wolff C, Khodadoust MS, Bensussan A, Paturel C, Bonnafous C, Sicard H, Azim HA Jr, Kim YH. IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial. Lancet Oncol 2019;20:1160-70. [PMID: 31253572 DOI: 10.1016/S1470-2045(19)30320-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 25] [Article Influence: 18.7] [Reference Citation Analysis]
9 Barata MC, Teixeira SP, Batista MD, Tomimori J, Landman G, Silva MRR. αEβ7 Expression Increases With the Extent of Cutaneous Involvement in Mycosis Fungoides. Am J Dermatopathol 2019;41:630-6. [PMID: 30839339 DOI: 10.1097/DAD.0000000000001397] [Reference Citation Analysis]
10 Hu T, Buus TB, Krejsgaard T, Nansen A, Lundholt BK, Spee P, Fredholm S, Petersen DL, Blümel E, Gluud M, Monteiro MN, Willerslev-Olsen A, Andersen MH, Straten PT, Met Ö, Stolearenco V, Fogh H, Gniadecki R, Nastasi C, Litman T, Woetmann A, Gjerdrum LMR, Ødum N. Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome. Oncotarget 2019;10:4894-906. [PMID: 31448055 DOI: 10.18632/oncotarget.27122] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 El-Ashmawy AA, Shamloula MM, Elfar NN. Podoplanin as a Predictive Marker for Identification of High-Risk Mycosis Fungoides Patients: An Immunohistochemical Study. Indian J Dermatol 2020;65:500-5. [PMID: 33487706 DOI: 10.4103/ijd.IJD_269_19] [Reference Citation Analysis]
12 Bobrowicz M, Slusarczyk A, Domagala J, Dwojak M, Ignatova D, Chang YT, Iselin C, Miazek-Zapala N, Marhelava K, Guenova E, Winiarska M. Selective inhibition of HDAC6 sensitizes cutaneous T-cell lymphoma to PI3K inhibitors. Oncol Lett 2020;20:533-40. [PMID: 32565979 DOI: 10.3892/ol.2020.11587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Erickson SP, Foshee JP, Council ML. Cells to Surgery Quiz: May 2021. J Invest Dermatol 2021;141:e59-63. [PMID: 33888220 DOI: 10.1016/j.jid.2021.03.003] [Reference Citation Analysis]
14 Iżykowska K. Methylation patterns of cutaneous T-cell lymphomas. Exp Dermatol 2021;30:1135-40. [PMID: 32350933 DOI: 10.1111/exd.14108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Nicolay JP, Albrecht JD, Alberti-Violetti S, Berti E. CCR4 in cutaneous T-cell lymphoma: Therapeutic targeting of a pathogenic driver. Eur J Immunol 2021;51:1660-71. [PMID: 33811642 DOI: 10.1002/eji.202049043] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Hignett E, Seminario-Vidal L, Shulman K, Sami N. Cutaneous T-cell lymphoma mimicking palmoplantar pustular psoriasis: A rare variant. Australas J Dermatol 2021;62:e280-2. [PMID: 33386610 DOI: 10.1111/ajd.13544] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Chen B, Zheng Y, Zhu J, Liang Y. SHARPIN overexpression promotes TAK1 expression and activates JNKs and NF-κB pathway in Mycosis Fungoides. Exp Dermatol 2019;28:1279-88. [PMID: 31461795 DOI: 10.1111/exd.14026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Aronovich A, Moyal L, Gorovitz B, Amitay-laish I, Naveh HP, Forer Y, Maron L, Knaneh J, Ad-el D, Yaacobi D, Barel E, Erez N, Hodak E. Cancer-Associated Fibroblasts in Mycosis Fungoides Promote Tumor Cell Migration and Drug Resistance through CXCL12/CXCR4. Journal of Investigative Dermatology 2021;141:619-627.e2. [DOI: 10.1016/j.jid.2020.06.034] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
19 Borcherding N, Voigt AP, Liu V, Link BK, Zhang W, Jabbari A. Single-Cell Profiling of Cutaneous T-Cell Lymphoma Reveals Underlying Heterogeneity Associated with Disease Progression. Clin Cancer Res 2019;25:2996-3005. [PMID: 30718356 DOI: 10.1158/1078-0432.CCR-18-3309] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 10.7] [Reference Citation Analysis]
20 Cayrol F, Sterle HA, Díaz Flaqué MC, Barreiro Arcos ML, Cremaschi GA. Non-genomic Actions of Thyroid Hormones Regulate the Growth and Angiogenesis of T Cell Lymphomas. Front Endocrinol (Lausanne) 2019;10:63. [PMID: 30814977 DOI: 10.3389/fendo.2019.00063] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
21 Cuesta-Mateos C, Terrón F, Herling M. CCR7 in Blood Cancers - Review of Its Pathophysiological Roles and the Potential as a Therapeutic Target. Front Oncol 2021;11:736758. [PMID: 34778050 DOI: 10.3389/fonc.2021.736758] [Reference Citation Analysis]
22 Lebas E, Collins P, Somja J, Nikkels AF. A Comprehensive Update of the Atypical, Rare and Mimicking Presentations of Mycosis Fungoides. Dermatol Ther (Heidelb) 2021;11:1931-51. [PMID: 34709600 DOI: 10.1007/s13555-021-00625-6] [Reference Citation Analysis]
23 Ollila TA, Sahin I, Olszewski AJ. Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma. Onco Targets Ther 2019;12:1085-94. [PMID: 30799938 DOI: 10.2147/OTT.S165615] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 8.3] [Reference Citation Analysis]
24 Cristofoletti C, Bresin A, Picozza M, Picchio MC, Monzo F, Helmer Citterich M, Passarelli F, Frezzolini A, Scala E, Monopoli A, Cantonetti M, Benucci R, D'Atri S, Caprini E, Russo G, Narducci MG. Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance. Leukemia 2019;33:1231-42. [PMID: 30518812 DOI: 10.1038/s41375-018-0305-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
25 Moyal L, Arkin C, Gorovitz-Haris B, Querfeld C, Rosen S, Knaneh J, Amitay-Laish I, Prag-Naveh H, Jacob-Hirsch J, Hodak E. Mycosis fungoides-derived exosomes promote cell motility and are enriched with microRNA-155 and microRNA-1246, and their plasma-cell-free expression may serve as a potential biomarker for disease burden. Br J Dermatol 2021. [PMID: 34053079 DOI: 10.1111/bjd.20519] [Reference Citation Analysis]
26 Amorim GM, Quintella DC, Niemeyer-Corbellini JP, Ferreira LC, Ramos-E-Silva M, Cuzzi T. Validation of an algorithm based on clinical, histopathological and immunohistochemical data for the diagnosis of early-stage mycosis fungoides. An Bras Dermatol 2020;95:326-31. [PMID: 32317132 DOI: 10.1016/j.abd.2020.01.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
27 Sernicola A, Russo I, Silic-Benussi M, Ciminale V, Alaibac M. Targeting the cutaneous lymphocyte antigen (CLA) in inflammatory and neoplastic skin conditions. Expert Opin Biol Ther 2020;20:275-82. [PMID: 31951753 DOI: 10.1080/14712598.2020.1715937] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Shimony S, Horowitz N, Ribakovsky E, Rozovski U, Avigdor A, Zloto K, Berger T, Avivi I, Perry C, Abadi U, Raanani P, Gafter-Gvili A, Gurion R. Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study. Hematol Oncol 2019;37:569-77. [PMID: 31674027 DOI: 10.1002/hon.2691] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
29 Wilcox RA. ECP in the spotLIGHT. Blood 2019;134:1275-7. [DOI: 10.1182/blood.2019002790] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
30 Hristov AC, Tejasvi T, A Wilcox R. Cutaneous T-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management. Am J Hematol 2021. [PMID: 34297414 DOI: 10.1002/ajh.26299] [Reference Citation Analysis]
31 Luca DA, Enz PA, Galimberti RL, Rinflerch AR. No detection of c-kit gene mutations in exons 9, 11, 13 and 17 and low CD117 expression in plaque-stage mycosis fungoides. An Bras Dermatol 2018;93:913-5. [PMID: 30484546 DOI: 10.1590/abd1806-4841.20187930] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Willerslev-Olsen A, Gjerdrum LMR, Lindahl LM, Buus TB, Pallesen EMH, Gluud M, Bzorek M, Nielsen BS, Kamstrup MR, Rittig AH, Bonefeld CM, Krejsgaard T, Geisler C, Koralov SB, Litman T, Becker JC, Woetmann A, Iversen L, Odum N. Staphylococcus aureus Induces Signal Transducer and Activator of Transcription 5‒Dependent miR-155 Expression in Cutaneous T-Cell Lymphoma. J Invest Dermatol 2021:S0022-202X(21)01148-9. [PMID: 33862068 DOI: 10.1016/j.jid.2021.01.038] [Reference Citation Analysis]
33 Larocca C, Kupper T. Mycosis Fungoides and Sézary Syndrome: An Update. Hematol Oncol Clin North Am 2019;33:103-20. [PMID: 30497668 DOI: 10.1016/j.hoc.2018.09.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
34 Pileri A, Guglielmo A, Fuligni F, Lastrucci I, Patrizi A, Pimpinelli N; Italian Lymphoma Foundation (FIL) - Cutaneous Lymphoma Task Force. Second neoplasm in cutaneous T-cell lymphoma patients: a marker of worse prognosis? Ital J Dermatol Venerol 2021;156:484-8. [PMID: 31804054 DOI: 10.23736/S2784-8671.19.06510-6] [Reference Citation Analysis]
35 Nanni L, Morigi A, Casadei B, Broccoli A, Stefoni V, Argnani L, Cavo M, Zinzani PL. A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapies. Hematol Oncol 2019;37:202-4. [PMID: 30637815 DOI: 10.1002/hon.2573] [Reference Citation Analysis]
36 Karagianni F, Piperi C, Mpakou V, Spathis A, Foukas PG, Dalamaga M, Pappa V, Papadavid E. Ruxolitinib with resminostat exert synergistic antitumor effects in Cutaneous T-cell Lymphoma. PLoS One 2021;16:e0248298. [PMID: 33705488 DOI: 10.1371/journal.pone.0248298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Rindler K, Bauer WM, Jonak C, Wielscher M, Shaw LE, Rojahn TB, Thaler FM, Porkert S, Simonitsch-Klupp I, Weninger W, Mayerhoefer ME, Farlik M, Brunner PM. Single-Cell RNA Sequencing Reveals Tissue Compartment-Specific Plasticity of Mycosis Fungoides Tumor Cells. Front Immunol 2021;12:666935. [PMID: 33968070 DOI: 10.3389/fimmu.2021.666935] [Reference Citation Analysis]
38 Fujii K. New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma. Front Oncol 2018;8:198. [PMID: 29915722 DOI: 10.3389/fonc.2018.00198] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
39 Bobrowicz M, Zagozdzon R, Domagala J, Vasconcelos-Berg R, Guenova E, Winiarska M. Monoclonal Antibodies in Dermatooncology-State of the Art and Future Perspectives. Cancers (Basel) 2019;11:E1420. [PMID: 31554169 DOI: 10.3390/cancers11101420] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
40 Fujii K, Kanekura T. Next-Generation Sequencing Technologies for Early-Stage Cutaneous T-Cell Lymphoma. Front Med (Lausanne) 2019;6:181. [PMID: 31457014 DOI: 10.3389/fmed.2019.00181] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
41 Mateeva V, Patsatsi A. Management of primary cutaneous lymphomas during the COVID-19 pandemic. Clin Dermatol 2021;39:64-75. [PMID: 33972055 DOI: 10.1016/j.clindermatol.2020.12.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Che Y, Ding X, Song J, Zhang X, Sun X, Xu L. Effective remission of chidamide on treatment of advanced mycosis fungoides: An unusual case report. Dermatologic Therapy 2019. [DOI: 10.1111/dth.12944] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
43 Willerslev-Olsen A, Buus TB, Nastasi C, Blümel E, Gluud M, Bonefeld CM, Geisler C, Lindahl LM, Vermeer M, Wasik MA, Iversen L, Becker JC, Andersen MH, Gjerdrum LMR, Litvinov IV, Litman T, Krejsgaard T, Woetmann A, Ødum N. Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndrome. Blood Cancer J 2020;10:57. [PMID: 32409671 DOI: 10.1038/s41408-020-0324-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
44 Kanda-Kato M, Yoshioka S, Ishikawa T. Haploidentical Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide for Sézary Syndrome. Case Rep Oncol 2020;13:1053-8. [PMID: 33082748 DOI: 10.1159/000509347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Vieyra-Garcia PA, Wolf P. A deep dive into UV-based phototherapy: Mechanisms of action and emerging molecular targets in inflammation and cancer. Pharmacol Ther 2021;222:107784. [PMID: 33316286 DOI: 10.1016/j.pharmthera.2020.107784] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
46 Dubyk F, Gru A, Flowers R. Refractory Hand Dermatitis With Massive Thumb Enlargement: Answer. Am J Dermatopathol 2019;41:775-6. [PMID: 31567298 DOI: 10.1097/DAD.0000000000001192] [Reference Citation Analysis]
47 Yang H, Tao Y, Zhang M, Ma P, Li L, Diao Q. Effects of 9-cis-retinoic acid on the proliferation and apoptosis of cutaneous T-cell lymphoma cells. Anticancer Drugs 2019;30:56-64. [PMID: 30198914 DOI: 10.1097/CAD.0000000000000692] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Sivanand A, Surmanowicz P, Alhusayen R, Hull P, Litvinov IV, Zhou Y, Gniadecki R. Immunotherapy for Cutaneous T-Cell Lymphoma: Current Landscape and Future Developments. J Cutan Med Surg 2019;23:537-44. [PMID: 31353944 DOI: 10.1177/1203475419867610] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
49 Murga-Zamalloa C, Wilcox RA. GATA-3 in T-cell lymphoproliferative disorders. IUBMB Life 2020;72:170-7. [PMID: 31317631 DOI: 10.1002/iub.2130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
50 Andrews JM, Schmidt JA, Carson KR, Musiek AC, Mehta-Shah N, Payton JE. Novel cell adhesion/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphoma. EBioMedicine 2019;46:170-83. [PMID: 31358475 DOI: 10.1016/j.ebiom.2019.07.053] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
51 Ortiz-Romero PL, Servitje O, Estrach MT, Izu-Belloso RM, Fernández-de-Misa R, Gallardo F, López-Martínez N, Pérez-Mitru A. Cost of early-stage mycosis fungoides treatments in Spain. Clinicoecon Outcomes Res 2020;12:91-105. [PMID: 32104021 DOI: 10.2147/CEOR.S233376] [Reference Citation Analysis]
52 Henry KA, Wiese D, Maiti A, Harris G, Vucetic S, Stroup AM. Geographic clustering of cutaneous T-cell lymphoma in New Jersey: an exploratory analysis using residential histories. Cancer Causes Control 2021;32:989-99. [PMID: 34117957 DOI: 10.1007/s10552-021-01452-y] [Reference Citation Analysis]
53 Kim EJ, Guitart J, Querfeld C, Girardi M, Musiek A, Akilov OE, Angello JT, Bailey WL, Geskin LJ. The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma. Am J Clin Dermatol 2021;22:407-14. [PMID: 33656660 DOI: 10.1007/s40257-021-00591-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
54 Bergallo M, DaprÀ V, Fava P, Ponti R, Calvi C, Fierro MT, Quaglino P, Galliano I, Montanari P. Lack of detection of Cutavirus DNA using PCR real time in cutaneous T-cell lymphomas. G Ital Dermatol Venereol 2020;155:772-4. [PMID: 30375215 DOI: 10.23736/S0392-0488.18.06161-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Hyde MA, Wada DA. Patient education and support group for patients with cutaneous lymphoma and their caregivers. Clin Exp Dermatol 2019;44:84-5. [PMID: 30132991 DOI: 10.1111/ced.13716] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Bolcato V, Barruscotti S, DE Silvestri A, Tomasini CF, Brazzelli V. Sézary Syndrome: a clinico-pathological study of 9 cases. Ital J Dermatol Venerol 2021;156:73-83. [PMID: 33084262 DOI: 10.23736/S2784-8671.19.06403-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Iluta S, Termure DA, Petrushev B, Fetica B, Badea ME, Moldovan-Lazar M, Lenghel M, Csutak C, Roman A, Pasca S, Zimta AA, Jitaru C, Tomuleasa C, Roman RC. Clinical Remission in a 72-Year-Old Patient with a Massive Primary Cutaneous Peripheral T-Cell Lymphoma-NOS of the Eyelid, Following Combination Chemotherapy with Etoposide Plus COP. Diagnostics (Basel) 2020;10:E629. [PMID: 32847118 DOI: 10.3390/diagnostics10090629] [Reference Citation Analysis]
58 Hong CH, Lin SH, Lee CH. CCL21 Induces mTOR-dependent MALAT1 Expression, Leading to Cell Migration in Cutaneous T-Cell Lymphoma. In Vivo 2019;33:793-800. [PMID: 31028199 DOI: 10.21873/invivo.11541] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
59 Kartan S, Shalabi D, O'Donnell M, Alpdogan SO, Sahu J, Shi W, Porcu P, Cha J, Nikbakht N. Response to topical corticosteroid monotherapy in mycosis fungoides. J Am Acad Dermatol 2021;84:615-23. [PMID: 32428610 DOI: 10.1016/j.jaad.2020.05.043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
60 Zhang Y, Song J, Rutenberg D, Sokol L. Hepatic Infiltration with Malignant T-cells Manifesting as Impending Acute Liver Failure in Sezary Syndrome. Mediterr J Hematol Infect Dis 2020;12:e2020007. [PMID: 31934317 DOI: 10.4084/MJHID.2020.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]